Factors Moving Markets - Research Report on Medivation, Inc., Dendreon Corporation, True Religion Apparel, Inc., V.F. Corporation and Electronic Arts Inc.

Mon Feb 25, 2013 8:02am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130225:nPn2245080


NEW YORK,  February 25, 2013  /PRNewswire/ --

Today, National Traders Association announced new research reports highlighting
Medivation, Inc. (NASDAQ: MDVN), Dendreon Corporation (NASDAQ: DNDN), True
Religion Apparel, Inc. (NASDAQ: TRLG), V.F. Corporation (NYSE: VFC) and
Electronic Arts Inc. (NASDQ: EA). Today's readers may access these reports free
of charge - including full price targets, industry analysis and analyst ratings
- via the links below.

Medivation, Inc. Research Report

Xtandi has been well-received by the market. Astellas, Medivation's partner, had
earlier provided Xtandi's net sales guidance of  $100 million  for the fiscal
year ending  Mar 31, 2013, but now expects its sales to reach even higher. More
details about enzulatamide research will be presented by Atellas and Medivation
on  February 14. The company is optimistic about the possibilities of Xtandi,
including a study that will allow patients who have not undergone chemotherapy
to use the drug, and also a study that allows Xtandi for breast cancer (Phase
I). The Full Research Report on Medivation, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free of
charge at: [http://www.Investors-Alliance.com/r/full_research_report/67e4_MDVN]

--

Dendreon Corporation Research Report

The company is seeking approval to sell Provenge in  Europe, allowing it to
expand its market. The final decision will be made in the middle of this year.
Closer to home, more doctors are starting to prescribe Provenge because it works
by training the immune system to target cancer cells as opposed to other drugs
that make use of other agents to fight cancer. Furthermore, Dendreon presently
has six drugs on Phase II and III statuses. These drugs include one that can
treat prostate cancer patients who have not undergone chemotherapy as well as a
new drug that targets cancer cells present in the bladder, ovary, prostate and
the breasts. The Full Research Report on Dendreon Corporation - including full
detailed breakdown, analyst ratings and price targets - is available to download
free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/402d_DNDN]

--

True Religion Apparel, Inc. Research Report

After almost a year of constant struggle, True Religion Apparel Inc. was still
able to close 2012 with positive Q4 results, proving all the negative
projections wrong, and starting to turn heads once again. Analysts said that the
company's Q4 was an impressive bounce-back after its two-year lag. This recovery
is highly attributed to the company's improving capability to generate
consistent cash flows despite the pangs of economic recession. Moreover, the
fashion industry in the global setting continues to improve, fueled by creative
advertising, pop culture and endorsements from famous personalities. The Full
Research Report on True Religion Apparel, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free of
charge at: [http://www.Investors-Alliance.com/r/full_research_report/1013_TRLG]

--

V.F. Corporation Research Report

More and more investors are eyeing the company not just because of its current
trading performance. It's also because of its impressive ability for expansive
growth while offering large dividends. At first glance, the current performance
of True Religion and VF shows that the apparel industry is on a steady rise
despite the tough economic climate. Both companies offer their products for a
premium which has turned their clothing lines into status symbols. The common
ground between True Religion Apparel and VF is the quality which has so far been
consistent. The signs are looking good for both companies and their peers as the
US economy is slowly recovering, but won't take off by the second half of 2013.
True Religion Apparel should focus more on keeping their numbers up to earn back
the full trust of their stakeholders. This will help the company grow and be
more capable of sustaining its global operations. The same is also true for VF,
in order for the company to retain their leadership in the fashion scene. The
Full Research Report on V.F. Corporation - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/d0b7_VFC]

--

Electronic Arts Inc. Research Report

A good portion of steady growth stem from FIFA sales, which sold over 12 million
units over the fiscal quarter. As the market continues to shift to mobile
gadgets, EA may need to further their research and development for cutting edge
mobile platforms as both companies continue to create new games that will engage
their markets. While EA is considered the #1 worldwide publisher on iOS for the
year, uncertainties towards iPhones and iPads may be an area of concern.
However, EA seems to be acting fast as it recently partnered with Samsung to
develop the Korean electronic company's game library. EA may also improve its
run rate with the help of Dead Space 3 which is considered one of the best games
of this generation. The Full Research Report on Electronic Arts Inc. - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/1414_EA]

--

Consider Investors-Alliance

Tired of hearing about the latest, greatest trade opportunity... only to realize
that the ship has long sailed? You need a strong, informative community in your
arsenal. Join the group that has been consistently identifying momentous
situations as they develop - long before they become the next top news on major
financial networks.

Contact:  Patricia Byers

Email:  press@Investors-Alliance.com

Main: +1-480-745-7826

SOURCE  Investors-Alliance

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.